Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Sep;340(3):218-25.
doi: 10.1097/MAJ.0b013e3181e939ab.

Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections

Michael S Bronze  1 , James B Dale
Affiliations
Review

Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections

Michael S Bronze et al. Am J Med Sci. 2010 Sep.

Abstract

Infections caused by virulent Gram-positive bacteria, such as Staphylococcus aureus, group B streptococci and group A streptococci, remain significant causes of morbidity and mortality despite progress in antimicrobial therapy. Despite significant advances in the understanding of the pathogenesis of infection caused by these organisms, there are only limited strategies to prevent infection. In this article, we review efforts to develop safe and effective vaccines that would prevent infections caused by these 3 pathogens.

PubMed Disclaimer

References

    1. Schaffer AC, Lee JC. Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Agents. 2008;32 (Suppl 1):S71–78. - PubMed
    1. Shinefield HR, Black S. Prospects for active and passive immunization against Staphylococcus aureus. Pediatr Infect Dis J. 2006;25:167–168. - PubMed
    1. Shinefield HR, Black S. Prevention of Staphylococcus aureus infections: advances in vaccine development. Expert Rev Vaccines. 2005;4:669–676. - PubMed
    1. Schaffer AC, Lee JC. Staphylococcal vaccines and immunotherapies. Infect Dis Clin North Am. 2009;23:153–171. - PubMed
    1. Middleton JR. Staphylococcus aureus antigens and challenges in vaccine development. Expert Rev Vaccines. 2008;7:805–815. - PubMed

MeSH terms

Substances